News About: Pharm. Industry
Pfizer and GSK had two different performances last yearThe two companies once competing for the first and second in sales in the pharmaceutical industry, Pfizer Korea and GSK Korea, have received contrary management performance in 2...
|
“The new drug development is the only way to overcome the situation,” reflecting decreases in salesman and increases in researchers
For the past 8 years, pharmaceutical companies have reorganized personnel structures.
While the number of salesman has constantly decreased from 35.3% in 2005 to 29.2% in 2013 with 6.1% differences, the number of res...
Multinational pharmaceutical companies betting everything on development of new drugs
While growth of multinational pharmaceutical companies in the domestic market has lost in speed, they tend to focus on development of new drugs.
One of the outstanding companies in the trend is MSD Korea. Last year, ...
The annual wage of employees in multinational pharmaceutical companies exceeds KRW 70 million in average
It is observed that the average annual wage of employees working in Korean branches of multinational pharmaceutical companies were over KRW 70 million and ones in UBC Korea recorded the highest annual wage with approx...
A half of domestic M&A cases are made between pharmaceutical companies
It is observed that M&As among pharmaceutical companies are more active than other industries.
The Korea Health Industry Development Institute analyzed M&A cases of global pharmaceutical companies between 2010 and 20...
The dermatological pharmaceutical company ‘Sinclair’ started the countdown to expand to the domestic marketAnother multinational pharmaceutical company specializing in dermatology is looking forward to expand to the domestic market.
According to the coverage result of Daily Pharm on...
|
28 multinational pharmaceutical companies spent 4.5%of sales and 6 spent more than KRW 10 billion
It is observed that Pfizer Korea was the company spent the most, KRW 45.471 billion on advertisements among Korean branches of multinational pharmaceutical companies entered in Korea.
Moreover, it is investigated tha...
MSD states “Keytruda is an innovative antibody that will create its own pipeline itself”The pharmaceutical industry has paid attention on the domestically first anti-PD-1 immunotherapy ‘Keytruda’.
On the 14th, MSD Korea announced that it held a press conference to...
|
GSK and SK will release competing products of the shingles vaccine ‘Zostavax’It is expected that competing products of the only herpes zoster vaccine ‘Zostavax’ will be launched.
According to the industry concerned on the 15th, a multinational company ‘...
|
50 multinational pharmaceutical companies recorded only a 1.4% increase in sales last year
Korean branches of multinational pharmaceutical companies, which have entered to the Korean market, also recorded poor sales performance last year due to governmental regulations and economic depression in the pharmac...
